Brought to you by 
Check-Cap's US IPO nets $11.2mm
23 Feb 2015
Executive Summary
Israeli cancer diagnostics company Check-Cap Ltd. netted $11.2mm through its initial public offering on the US Nasdaq market. The company sold 2mm ordinary shares at $6 (it planned to sell 1.2mm shares at $10-12), and also issued 1mm five-year Series A warrants to purchase ordinary shares at $7.50.
Deal Industry
- Medical Devices
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- X-ray
-
Diagnostic Imaging Equipment & Supplies
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Check-Cap's US IPO nets $11.2mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice